Recce Pharmaceuticals Ltd (ASX:RCE)

Australia · Delayed Price · Currency is AUD

0.4450

-0.0150 (-3.26%)

Mar 31, 2026, 4:10 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Research and Development of Pharmaceutical Drugs	7.51M	5.03M	4.37M	3.08M	1.64M
Research and Development of Pharmaceutical Drugs Growth	49.33%	15.19%	41.50%	88.41%	45.97%
Total	7.51M	5.03M	4.37M	3.08M	1.64M
Total Growth	49.33%	15.19%	41.50%	88.41%	45.97%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Australia	5.29M	3.83M	4.34M	2.84M	1.80M
Australia Growth	38.05%	-11.66%	53.07%	57.22%	125.84%
USA	1.65M	1.37M	58.47K	317.16K	134.17K
USA Growth	20.07%	2251.32%	-81.56%	136.38%	-61.45%
Unallocated	733.30K	-	-	-	-
UK	26.84K	26.81K	32.07K	23.01K	25.33K
UK Growth	0.12%	-16.41%	39.38%	-9.18%	3194.28%
Total	7.70M	5.24M	4.43M	3.18M	1.96M
Total Growth	47.14%	18.17%	39.53%	61.77%	71.09%

Source: S&P Global Market Intelligence.